EXO1 and ductal breast carcinoma in situ: Apart from the reported polymorphisms [34-36] and elevated expression of EXO1 in Ductal carcinoma in situ [33], also there are contradicting reports relating EXO1 loss of function to increased susceptibility to lymphomas [37], urging the need for further investigation.